An invitro study of the effect of probiotics, prebiotics and synbiotics on the elderly faecal microbiota

Anaerobe

Volumn 27, Issue , 2014, Pages 50-55

  Likotrafiti, Eleni ^a   Tuohy, Kieran M ^b   Gibson, Glenn R ^c   Rastall, Robert A ^c  

^a Laboratory of Food Technology   (Greece)

^b RESEARCH AND INNOVATION CENTRE   (Italy)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

Elderly; Prebiotics; Probiotics; Synbiotics

Indexed keywords

OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

AGED; BACTERIAL LOAD; BIFIDOBACTERIUM; BIOTA; CASE REPORT; DRUG EFFECTS; FECES; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LACTOBACILLUS FERMENTUM; MALE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

AGED; BACTERIAL LOAD; BIFIDOBACTERIUM; BIOTA; FECES; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LACTOBACILLUS FERMENTUM; MALE; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; SYNBIOTICS;

EID: 84898604796     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.03.009     Document Type: Article

References (45)

1. Tuohy K.M., Likotrafiti E., Manderson K., Gibson G.R., Rastall R.A. Improving gut health in the elderly. Functional foods, ageing and degenerative disease 2004, 394-415. Woodhead Publishing Ltd, Cambridge ( C. Remacle, B. Reusens (Eds.).
2. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 2010, 5(5):e10667. 10.1371/journal.pone.0010667.
3. Duncan S.H., Flint H.J. Probiotics and prebiotics and health in ageing populations. Maturitas 2013, 75(1):44-50.
4. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. PNAS 2011, 108:4586-4591.
5. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtedvt T., et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross sectional study. Appl Environ Microbiol 2006, 72:1027-1033.
6. Zwielehner J., Liszt K., Handschur M., Lassl C., Lapin A., Haslberger A.G. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 2009, 44:440-446.
7. Tiihonen K., Ouwehand A.C., Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev 2009, 9:107-116.
8. Gibson G.R. Fibre and effects on probiotics (the prebiotic concept). Clin Nutr Suppl 2004, 1:25-31.
9. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 1998, 35:180-187.
10. Gibson G.R., Cummings J.H., Macfarlane G.T. Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulphate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol 1988, 54:2750-2755.
11. Probert H.M., Apajalahti J.H.A., Rautonen N., Stowell J., Gibson G.R. Polydextrose, lactitol, andfructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl Environ Microbiol 2004, 70:4505-4511.
12. Van den Abbeele P., Grootaert C., Marzorati M., Possemiers S., Verstraete W., Gérard P., et al. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ Microbiol 2010, 76:5237-5246.
13. Likotrafiti E., Tuohy K.M., Gibson G.R., Rastall R.A. Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum. Anaerobe 2013, 20:5-13.
14. Likotrafiti E., Manderson K.S., Fava F., Tuohy K.M., Gibson G.R., Rastall R.A. Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly individuals. Microb Ecol Health Dis 2004, 16:105-112.
15. Beerens H. Detection of bifidobacteria by using propionic acid as a selective agent. Appl Environ Microbiol 1991, 57:2418-2419.
16. Saulnier D.M., Gibson G.R., Kolida S. Invitro effects of selected synbiotics on the human faecal microbiota composition. FEMS Microbiol Ecol 2008, 66:516-527.
17. Rycroft C.E., Jones M.R., Gibson G.R., Rastall R.A. Acomparative invitro evaluation of the fermentation properties of prebiotic oligosaccharides. JAppl Microbiol 2001, 91:878-887.
18. Langendijk P.S., Schut F., Jansen G.J., Raangs G.W., Kamphuis G.R., Wilkinson M.H.F., et al. Quantitative fluorescent in situ hybridisation of Bifidobacterium spp. with genus specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995, 61:3069-3075.
19. Manz W., Amann R., Ludwig W., Vancanneyt M., Schleifer K.H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 1996, 142:1097-1106.
20. Franks A.H., Harmsen H.J.M., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridisation with group specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64:3336-3345.
21. Harmsen H.J.M., Elfferich P., Schut F., Welling G.W. A16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridisation. Microb Ecol Health Dis 1999, 11:3-12.
22. 1-3. JNutr 2007, 137:2503S-2506S.
23. Yen C.-H., Tseng Y.-H., Yi-Wen K., Meng-Chih L., Hsiao-Ling C. Long-term supplementation of isomalto-oligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people. A placebo-controlled, diet-controlled trial. Nutrition 2011, 27:445-450.
24. Kaplan H., Hutkins R.W. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Appl Environ Microbiol 2000, 66:2682-2684.
25. Wang X., Gibson G.R. Effects of the invitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. JAppl Bacteriol 1993, 75:373-380.
26. Gibson G.R., Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 1994, 118:121-128.
27. Gibson G.R., Beatty E.B., Wang X., Cummings J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995, 108:975-982.
28. Bouhnik Y., Flourié B., Riottot M., Bisetti N., Galling M.F., Guibert A., et al. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes in colon carcinogenesis in healthy humans. Nutr Cancer 1996, 26:21-29.
29. Sghir A., Chow J.M., Mackie R.I. Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharides as selective substrate. JAppl Microbiol 1998, 85:769-777.
30. Guigoz Y., Rochat F., Perruisseau-Carrier G., Rochat I., Schiffrin E.J. Effects of oligosaccharide on the faecal flora and non-specific immune system in the elderly people. Nutr Res 2002, 22:13-25.
31. Bouhnik Y., Achour L., Paineau D., Riottot M., Attar A., Bornet F. Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutr J 2007, 6:42.
32. Bouhnik Y., Vahedi K., Achour L., Attar A., Salfati J., Pochart P., et al. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. JNutr 1999, 129:113-116.
33. Hidaka H., Eida T., Takizawa T., Tokunaga T., Tashiro Y. Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria Microflora 1986, 5:37-50.
34. Mitsouka T., Hidaka H., Eida T. Effects of fructo-oligosaccharides on intestinal flora. Mol Nutr Food Res 1987, 31:427-436.
35. Probert H.M., Gibson G.R. Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Lett Appl Microbiol 2002, 35:473-480.
36. Bernalier A., Dore J., Durand M. Biochemistry of fermentation. Colonic microbiota, nutrition and health 1999, 37-53. Kluwer Academic Publishers, Dordrecht, The Netherlands. G.R. Gibson, M.B. Roberfroid (Eds.).
37. Scharrer E., Lutz T. Effects of short-chain fatty acids and K on absorption of Mgand other cations by the colon and caecum. ZErnahrungswiss 1990, 29:162-168.
38. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004, 70:5810-5817.
39. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. JAppl Bacteriol 1992, 72:57-64.
40. Yajiima T. Contractile effect of short-chain fatty acids on the isolated colon of the rat. JPhysiol 1985, 368:667-678.
41. Sakata T. Effects of short-chain fatty acids on the proliferation of gut epithelial cells invivo. Physiological and clinical aspects of short-chain fatty acids 1995, 289-306. Cambridge University Press, Cambridge. J.H. Cummings, J.L. Rombeau, T. Sakata (Eds.).
42. Ooi L.-G., Liong M.-T. Cholesterol-lowering effects of probiotics and prebiotics: a review of invivo and invitro findings. Int J Mol Sci 2010, 11:2499-2522.
43. Wong J.M., de Souza R., Kendall C.W., Emam A., Jenkins D.J. Colonic health: fermentation and short chain fatty acids. JClin Gastroenterol 2006, 40:235-243.
44. Cummings J.H., Macfarlane G.T. Areview: the control and consequences of bacterial fermentation in the human colon. JAppl Bact 1991, 70:443-459.
45. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-185.